ASLAN Pharmaceuticals Limited, a biopharmaceutical company focused on clinical phase immunology, is dedicated to developing various treatments to transform the lives of patients. The company is headquartered in Singapore. Show more

3 TEMASEK AVENUE, SINGAPORE, SINGAPORE, 039190, 12 03 Ue Square, 239920, USA

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

1.697M

52 Wk Range

$0.00 - $0.00

Previous Close

$0.60

Open

$0.60

Volume

N/A

Day Range

$0.60 - $0.60

Enterprise Value

0.00

Cash

18.4M

Avg Qtr Burn

N/A

Insider Ownership

0.14%

Institutional Own.

13.21%

Qtr Updated

03/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Eblasakimab (ASLAN004) (IL-13Ra1 inhibitor) Details Atopic dermatitis	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Farudodstat (ASLAN003) (DHODH inhibitor) Details Autoimmune disease, Alopecia areata	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Eblasakimab Details Atopic dermatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.